Heterogeneity in renal cell carcinoma

AT Beksac, DJ Paulucci, KA Blum, SS Yadav… - … Oncology: Seminars and …, 2017 - Elsevier
Introduction In recent years, molecular characterization of renal cell carcinoma has
facilitated the identification of driver genes, specific molecular pathways, and …

Genomics and clinical correlates of renal cell carcinoma

TJ Mitchell, SH Rossi, T Klatte, GD Stewart - World Journal of Urology, 2018 - Springer
Purpose Clear cell, papillary cell, and chromophobe renal cell carcinomas (RCCs) have
now been well characterised thanks to large collaborative projects such as The Cancer …

A CT-based deep learning radiomics nomogram outperforms the existing prognostic models for outcome prediction in clear cell renal cell carcinoma: A multicenter …

P Nie, G Yang, Y Wang, Y Xu, L Yan, M Zhang… - European …, 2023 - Springer
Objectives To develop and validate a CT-based deep learning radiomics nomogram (DLRN)
for outcome prediction in clear cell renal cell carcinoma (ccRCC), and its performance was …

miR-4521-FAM129A axial regulation on ccRCC progression through TIMP-1/MMP2/MMP9 and MDM2/p53/Bcl2/Bax pathways

X Feng, N Yan, W Sun, S Zheng, S Jiang, J Wang… - Cell Death …, 2019 - nature.com
Clear cell renal cell carcinoma (ccRCC) is the most aggressive RCC subtype with high
metastasis, chemotherapy and radiotherapy resistance, and poor prognosis. This study …

Integrin signaling potentiates transforming growth factor-beta 1 (TGF-β1) dependent down-regulation of E-Cadherin expression–Important implications for epithelial to …

B Feldkoren, R Hutchinson, Y Rapoport… - Experimental Cell …, 2017 - Elsevier
Signal transduction through the transforming growth factor-beta 1 (TGF-β1) pathway affects
epithelial to mesenchymal transition (EMT), partly by modulation of E-Cadherin expression …

Towards personalized sampling in clear cell renal cell carcinomas

C Manini, E López-Fernández, JI López - Cancers, 2022 - mdpi.com
Simple Summary Intratumor heterogeneity (ITH) is a constant event in malignant tumors and
the cause of most therapeutic failures in modern oncology. Since clear cell renal cell …

Gene expression analysis of aggressive clinical T1 stage clear cell renal cell carcinoma for identifying potential diagnostic and prognostic biomarkers

JS Park, PM Pierorazio, JH Lee, HJ Lee, YS Lim… - Cancers, 2020 - mdpi.com
The molecular characteristics of early-stage clear cell renal cell carcinomas (ccRCCs)
measuring≤ 7 cm associated with poor clinical outcomes remain poorly understood. Here …

Pathological bases and clinical impact of intratumor heterogeneity in clear cell renal cell carcinoma

JI Lopez, JC Angulo - Current Urology Reports, 2018 - Springer
Abstract Purpose of Review Intratumor heterogeneity is an inherent event in tumor
development that is receiving much attention in the last years since it is responsible for most …

Intratumor heterogeneity in clear cell renal cell carcinoma: a review for the practicing pathologist

JI López - Apmis, 2016 - Wiley Online Library
Intertumor heterogeneity, defined as the spectrum of morphological differences found in
similar tumors in different patients, is a well‐known event for pathologists. However, recent …

Multisite tumor sampling: a new tumor selection method to enhance intratumor heterogeneity detection

JI Lopez, JM Cortes - Human Pathology, 2017 - Elsevier
Intratumor heterogeneity (ITH) is increasingly being recognized as a highly complex process
with high clinical impact that deserves special attention from practicing pathologists. The …